Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Eur J Cancer. 2013 Nov 15;50(2):302–308. doi: 10.1016/j.ejca.2013.10.006

Table 3.

Treatment-Related Toxicity

Toxicity Type Treatment Arm
A (n=135)
Grade
1 (%) 2 (%) 3 (%) 4 (%) 5 (%)
Hemoglobin 27 4 - - -
Fatigue 30 25 10 1 -
Weight loss 19 7 1 - -
Dry skin 27 12 2 - -
Alopecia 18 2 - - -
Pruritus/itching 27 13 1 - -
Rash/desquamation 3 5 1 - -
Rash: acne/acneiform 28 39 9 - -
Erythema multiforme - 1 - - -
Hand-foot reaction 1 2 1 - -
Diarrhea w/o prior colostomy 38 20 10 - -
Dry mouth 16 1 - - -
Dysphagia 1 1 - - -
Muco-stomatitis (symptom) oral cavity 16 7 1 - -
Nausea 25 11 4 - -
Vomiting 14 3 3 - -
Alkaline phosphatase 9 2 - - -
ALT, SGPT 9 2 1 1 -
AST, SGOT 8 2 2 - -
Bilirubin 12 9 - - -
Hyperglycemia 19 3 1 - -
Hyponatremia 12 - 2 - -
Dry eye syndrome 7 1 1 - -
Pneumonitis/pulmonary infiltrates - - 1 - 1